Skip to main content
PLOS One logoLink to PLOS One
. 2021 Nov 5;16(11):e0258700. doi: 10.1371/journal.pone.0258700

Regular testing of asymptomatic healthcare workers identifies cost-efficient SARS-CoV-2 preventive measures

Daniel Sanchez-Taltavull 1,2,3,*, Violeta Castelo-Szekely 1,2,3, Shaira Murugan 1,2,3, Jonathan I D Hamley 1,2,3, Tim Rollenske 1,2, Stephanie C Ganal-Vonarburg 1,2, Isabel Büchi 1,2,3, Adrian Keogh 1,2,3, Hai Li 1,2, Lilian Salm 1,2,3, Daniel Spari 1,2,3, Bahtiyar Yilmaz 1,2, Jakob Zimmermann 1,2, Michael Gerfin 4, Edgar Roldan 5, Guido Beldi 1,2,3,*; UVCM-COVID researchers1,2,3,
Editor: Etsuro Ito6
PMCID: PMC8570514  PMID: 34739484

Abstract

Protecting healthcare professionals is crucial in maintaining a functioning healthcare system. The risk of infection and optimal preventive strategies for healthcare workers during the COVID-19 pandemic remain poorly understood. Here we report the results of a cohort study that included pre- and asymptomatic healthcare workers. A weekly testing regime has been performed in this cohort since the beginning of the COVID-19 pandemic to identify infected healthcare workers. Based on these observations we have developed a mathematical model of SARS-CoV-2 transmission that integrates the sources of infection from inside and outside the hospital. The data were used to study how regular testing and a desynchronisation protocol are effective in preventing transmission of COVID-19 infection at work, and compared both strategies in terms of workforce availability and cost-effectiveness. We showed that case incidence among healthcare workers is higher than would be explained solely by community infection. Furthermore, while testing and desynchronisation protocols are both effective in preventing nosocomial transmission, regular testing maintains work productivity with implementation costs.

Introduction

During the outbreak and spread of an epidemic such as that of SARS-CoV-2, protection of individuals relies on non-pharmaceutical interventions (NPIs) at least until a large fraction of the population is vaccinated. Common NPIs include wearing protective equipment, social distancing and working from home, as well as isolation of symptomatic individuals. However, applying some of these measures among healthcare workers is challenging, as they need to work in close contact with infected patients and with their coworkers, and as the possibilities for home-office options are limited. Therefore, the healthcare workforce could be exposed to an increased risk of infection transmission than the general population and devising protective strategies for them remains a crucial task. In addition to the above, other NPIs have been considered through modelling and case studies, notably, testing of healthcare personnel and implementation of desynchronisation to reduce worker contact.

Studies of testing healthcare workers have shown differing results with regard to whether they have a reduced or increased case incidence with respect to the general population. The incidence among health workers seems to be increased [1] although it mirrored the curve in the general population [2]. Other studies showed no major occupational risk for healthcare professionals [3, 4]. Together, these results indicate that the exposure risk among healthcare workers likely depends on the specificities of the study as well as on the local magnitude of the epidemic, the availability and implementation of basic protective measures and the effective adherence to them in the studied scenario. As a caveat, most of these studies carried out testing only on symptomatic individuals and did not assess whether widespread regular testing of asymptomatic and pre-symptomatic coworkers reveals a higher incidence and can prevent transmission at the workplace in an epidemic in which a significant proportion of affected individuals can present without symptoms [5, 6].

The implementation of desynchronising the presence of workers at the workplace has been modelled in the context of the SARS-CoV-2 epidemic. A model of 4-day work, 10-day lockdown cycle showed that these cycles can allow economic activity to partially continue by exploiting the latent period of the virus and allowing those infected at work to reach maximum infectiousness while at home [7]. Similarly, organisation of laboratory or clinical staff into smaller groups working shorter shifts can lead to reduced interaction and transmission among coworkers [8, 9]. Yet such models have not been tested in with experimental data during the current pandemic.

In this study we report the results of a testing pipeline of one clinical department that has been introduced from the beginning of the epidemic in Switzerland. Starting from March 23rd 2020, we implemented a RT-PCR-based testing pipeline that was applied weekly on a voluntary basis to a cohort of asymptomatic healthcare workers. Based on the results of this testing pipeline we have developed a mathematical model that includes the transmission dynamics of SARS-CoV-2 in the Swiss Canton of Bern, and that integrates the infection forces among a group of healthcare workers—including the general population, hospitalised patients and coworker—as independent sources of infection. Individuals testing positive were referred for confirmation to a second testing pipeline carried out by the official authorities, and sent into self-isolation.

We used this data not only to detect and isolate pre- and asymptomatic cases, but also to inform the model on the contribution of worker-worker and worker-patient contact to case incidence among the studied healthcare group. As a comparison, we have modelled a work desynchronisation strategy in which healthcare workers would shift weekly between in-hospital and at-home work, as a way to contain infection transmission by reducing contact between colleagues.

Given that the number of people tested may underestimate the true incidence, we have estimated the true incidence based on the number of hospitalized patients as it is a more reliable measure. Therefore, we fitted the model to the recorded number of hospitalised individuals in the canton of Bern to infer the time-varying infection rate of the general population, and we estimated the additional infection forces affecting the health workforce by fitting the individuals testing positive and sent to quarantine. The model allowed us to study how both regular testing of all individuals and desynchronisation strategies are efficient in preventing workers from infecting each other under the different scenarios, and we present how the model can help decision making on whether to implement such strategies. Furthermore, we studied the impact that the implementation of these interventions would have on productivity and the availability of the workforce, and compare them from an economic point view.

Materials and methods

Epidemiological data

We collected publicly available data on patient hospitalizations, deaths and confirmed cases in the Canton of Bern from March 1st 2020 to March 1st 2021, from the BAG (Bundesamt für Gesundheit) [10]. From the publicly available data we selected the sum of the last 7 days of infected and hospitalizations in the region of Bern.

Internal testing pipeline

The Study was approved by the ethical committee of the Canton of Bern (2020–00563). A cohort study was performed that included healthcare workers of the Department for Visceral Surgery and Medicine of the Bern University Hospital. A testing protocol was established and implemented weekly on a voluntary basis, starting March 23, 2020. Informed consent was obtained by all participants. Consenting participants could get tested either on Monday or Thursday every week, and positive cases were sent for a confirmatory test carried out by official institutions and isolated.

Sample collection

Healthcare workers collecting samples from the participants were instructed to use personal protective equipment including FFP-2 face masks, eye protection and face shield, two layers of gloves and two layers of hairnets. Nasopharyngeal specimens were obtained by slowly and gently inserting a MiniTip swab through the nostril palate and closely to the septum until contact with the nasopharynx was reached. The swab was removed after gently rubbing and rolling at the nasopharynx. Rarely, oral swabs were taken instead by taking samples from the posterior oropharynx. Specimens taken from each participant were immediately placed into 2-ml tubes containing TRIzol (Invitrogen), an acid-guanidinium-phenol based reagent that inactivates the virus and stabilises the RNA. All collected samples were sprayed with 70% EtOH before leaving the collection site. Specimens were further processed on the same day or kept at -20°C until processed the following day.

RNA extraction and RT-qPCR

Laboratory workers handling the collected samples were instructed to use personal protective equipment including gowns, facemask and two layers of gloves. The virus was inactivated by vortexing the TRIzol tube containing the swab-tips and 3.3 ng carrier RNA (Qiagen) was added. Then 200 μl of chloroform was added to each sample and the tubes were inverted multiple times, followed by centrifugation for 10 min at 13,200 rpm. RNA purification and concentration was carried out using RNA easy-mini elute kit (Qiagen) according to the manufacturer’s protocol. Briefly, 270 μl of the clear aqueous phase of each sample was re-suspended with 945 μl of RLT buffer and 670 μl of 100% EtOH. The sample was added to the column in three steps with intermittent centrifugation at 8000 rpm for 15 s allowing all sample to pass through the column. 500 μl of RPE buffer was added to each column as a first washing step and centrifuged at 8000 rpm for 15 s. Subsequently, 500 μl of 80% EtOH was added to each column and centrifuged at 13,200 rpm for 1 min. After drying the RNA containing membrane by centrifugation at 13,200 rpm for 3 min, 20 μl RNAse-free water was added to elute the RNA. The sample was incubated for 1 min at room temperature before it was centrifuged for 1 min at 13200 rpm.

One-step combined reverse transcription and qPCR using SuperScript III One-Step RT-PCR System with Platinum Taq DNA Polymerase (Invitrogen) was performed using the manufacturers recommended protocol. Briefly, 2 μl of each RNA sample was amplified using primers for SARS-Cov2 E-gene, which codes for protein forming pores on the host membrane, and human RNase-P, in order to verify successful sampling of the healthcare workers. Technical triplicates were performed. The PCR was run under following conditions: 50°C for 10 min, 95°C for 3 min, followed by 45 cycles of 95°C for 15 s and 58°C for 30 s on the BioRad CFX 384 real time PCR system.

The results for the RT-qPCR are displayed by ct (cycle threshold) values. In the current study the detection limit is at a ct of 40 and above. Values below a ct of 32 indicate high viral titers.

Mathematical modelling

Transmission dynamics in the city model

We developed a population-based model that integrates the transmission dynamics in the Swiss Canton of Bern as a deterministic model, and the infection dynamics among a group of healthcare workers, studied as a stochastic system (Fig 2A). The Canton dynamics are given by the following system of differential ordinary equations (ODE):

dSCdt=-α(t)SCIC (1)
dECdt=α(t)SCIC-sEC (2)
dICdt=sEC-r(1-ϵ1)IC-hϵ1IC (3)
dHCdt=hϵ1IC-w(1-ϵ4)HC-dϵ4HC (4)
dRCdt=r(1-ϵ1)IC+w(1-ϵ4)HC (5)
dDCdt=dϵ4HC (6)

Susceptible individuals in the Canton, SC, get exposed at a rate α; exposed individuals, EC, then become infectious, IC, after a latency period s−1. A proportion ϵ1 of infected individuals are hospitalised, HC, at a rate h. Infectious individuals recover, RC at a rate r, whereas hospitalised patients recover at a rate w. We only considered deaths from hospitalised people: a proportion ϵ4 of HC die at a rate d. N refers to the total population in the Canton of Bern.

As in Althaus et al. [11], the transmission rate α captures the reduction in the infections following the implementation of NPIs by the government, described as:

α(t)=πN(1-1-κ1+e-υ(t-τ)) (7)

where πN is the infection at the start of the epidemic, κ is the relative transmission reached after implementation of NPIs, ν is the slope of the sigmoid function, and τ is the midpoint of transmission reduction.

Transmission dynamics among the healthcare workers model

The transmission dynamics among the HCW are formulated in terms of the Master Equation [12]

P(X,t)t=j(Wj(X-rj,t)P(X-rj,t))-Wj(X,t)P(X,t)) (8)

where X = (S, E, I, A, R, Q) is the state vector containing the number of healthy workers susceptible to infection, S, the number of exposed workers who are infected but still not contagious that are working, E, the number of symptomatic infected workers, I, the number of asymptomatic infected workers, A, that are working, the number of recovered workers R, and the number of exposed and asymptomatic workers that have been identified as infected with a PCR test and put in quarantine, Q. P(X, t) is the probability of the population of having value X at time t. The transition rate per unit time of the process j is given by Wj(X, t), and rj is the state change in X upon the occurrence of the process j. All reactions and rates are described in Table 1. Due to the small size of our cohort, we do not consider differences such as age or type of job in the model.

Table 1. Reaction rates of the stochastic dynamics described by Eq 8.
Transition rate State change vector rj = (ΔS, ΔE, ΔI, ΔA, ΔR, ΔQ) Description
W1 = α(t)aIC S (−1, 1, 0, 0, 0, 0) SE
W2=βNHAS (−1, 1, 0, 0, 0, 0) S + AE + A
W3=γNSHC (−1, 1, 0, 0, 0, 0) SE
W4 = sEϵ2 (0, −1, 1, 0, 0, 0) EI
W5 = sE(1 − ϵ2) (0, −1, 0, 1, 0, 0) EA
W6 = rI (0, 0, −1, 0, 1, 0) IR
W7 = rA (0, 0, 0, −1, 1, 0) AR
W8 = p(t)ϵ3 E (0, −1, 0, 0, 0, 1) EQ
W9 = p(t)ϵ3 A (0, 0, 0, −1, 0, 1) AQ
W10 = rQ (0, 0, 0, 0, 1, −1) QR

The mean-field dynamics of the stochastic system are given by the following system of ODEs:

dSdt=-α(t)aSIC-βSANH-γSHCN (9)
dEdt=α(t)aSIC+βSANH+γSHCN-sϵ2E-s(1-ϵ2)E-p(t)ϵ3E (10)
dIdt=sϵ2E-rI (11)
dAdt=s(1-ϵ2)E-rA-p(t)ϵ3A (12)
dRdt=rA+rI+rQ (13)
dQdt=p(t)ϵ3E+p(t)ϵ3A-rQ (14)

Susceptible workers, S, become exposed at a rate α due to contact with the general population (IC), at a rate β from being in contact with an asymptomatic coworker (A, see later), and at a rate γ from contact with infected hospitalised individuals (HC). Exposed individuals (E) then develop the disease after a latency period s−1, and become either infectious and symptomatic, I, or infectious and asymptomatic, A, with the probability of being I or A given by ϵ2 and 1-ϵ2 respectively. Exposed and asymptomatic can be identified by testing, where ϵ3 is the probability of obtaining a true positive in the test, and the details of the testing are described below. For simplicity, we write p(t) in the equations to show it is time dependent. Finally, r is the recovery rate.

Both asymptomatic and symptomatic individuals recover at a rate r. We did not considered deaths among healthcare workers. NH refers to the number of healthcare workers participating in the study. Due to their small number, their transmission dynamics are studied as a stochastic process using Gillespie simulations [13].

Modelling a desynchronisation strategy

We modelled a desynchronisation strategy in which the workforce was split into two non-mixing groups to establish a weekly rotation shift: Group 1 works in-hospital during odd weeks and at-home during even weeks, and Group 2 works at-home during odd weeks and in-hospital during even weeks.

To mathematically formulate the desynchronisation, each variable is dichotomised in two non-interacting groups (S1, E1, I1, A1, R1, Q1) and (S2, E2, I2, A2, R2, Q2), each of them described by Eq 8. When workers are doing home office, they cannot be infected by other co-workers nor by patients. That is, the parameters β and γ become time dependent, being β1(t) = 1.5β, γ1(t) = 1.5γ, β2(t) = 0, γ2(t) = 0 during the odd weeks, and exchanging values during the even weeks, β1(t) = 0, γ1(t) = 0, β2(t) = 1.5β, γ2(t) = 1.5γ. We assume an increase of 50% in β and γ because some tasks imply cooperation between workers.

Modelling testing

We modelled the testing as an instantaneous reaction in which EQ or AQ. Every P days, for each infected worker we generate a random number, x in (0, 1), if x < ϵ3 fp, where fp is the fraction of workers tested and ϵ3 is the probability of detecting a true positive, the worker is sent to quarantine. During the first wave, that is t < 91, on average 65% of the workers were tested every week, afterwards 45% were tested every week. Thus, fp = 0.65 for t < 91 and fp = 0.45 for t ≥ 91.

Model fitting

City. In Switzerland the first lockdown was started on March 16th 2020 that included reduction of elective healthcare-associated interventions such as surgery until April 27th 2020. With the onset of the second wave national measures were again installed by October 19th 2020. After a second peak in 30th October 2020 the second wave faded by end of January 2021.

τ, π, ν and κ were chosen to obtain the best fit of the model to the data, by minimizing

G(κ,ν,π,τ)=i=0n((Hci(ti)-O(ti))2, (15)

with ti ∈ {0, 7, 14, …}, O(ti) the sum of the number of cases of the last 7 days at time ti starting March 1st 2020 (t = 0) and

Hci(ti)=ti-7tihϵ1Icdt

The fitting was done in 4 parts:

  1. Wave 1: With the initial condition (SC, EC, IC, HC, RC, DC) = (N − 1, 0, 1, 0, 0, 0) starting Day -8 to Day 91, with α(t) described by 7 resulting into τ = 17.4352, π = 1.2801, κ = 0.016, ν = 1.5. The optimization was performed with the R function optim with method=“L-BFGS-B” in the parameter region π ∈ [0, 2], ν ∈ [0, 1.5], κ ∈ [0, 0.15], and τ ∈ [15, 24].

  2. Summer: Day 91 to Day 189

    In this scenario, we consider a different α(t),
    α(t)=πN (16)
    The reason for this difference, is that during this period, there were no remarkable non-therapeutic interventions to reduce the number of cases. Instead, we assume it to be a period where the use of contact-tracing measures avoided a large increase in the number of cases. This difference is equivalent to the assumption κ = 1.

    The optimization resulting into π = 0.2869. The optimization was performed with the R function optim with method=“L-BFGS-B” in the parameter region π ∈ [0, 1].

    Eventually, the contact-tracing measures were overwhelmed by the number of cases, and the second wave started, were we considered a Holling type-II function to describe the dynamics.

  3. Wave 2: Day 189 to Day 273, with α(t) described by 7 resulting into τ = 240.2609, π = 0.3177, κ = 0.44, ν = 0.8934. The optimization was performed with the R function optim with method=“L-BFGS-B” in the parameter region π ∈ [0, 0.7], ν ∈ [0, 1.5], κ ∈ [0, 1], and τ ∈ [230, 246].

  4. Winter: Day 273 to Day 365, with α(t) described by 7 resulting into τ = 301.6273, π = 0.1919, κ = 0.6048, ν = 1.5. The optimization was performed with the R function optim with method=“L-BFGS-B” in the parameter region π ∈ [0, 0.5], ν ∈ [0, 1.5], κ ∈ [0, 1], and τ ∈ [295, 305].

The trajectory of α is shown in S1 Fig. The selection of the range for ν is arbitrary. We limited it to 1.5 because it would produce a change in α faster than the temporal resolution of our data and we decided not to allow this. In S2 Fig we show the fit without this limitation and the difference is negligible.

Hospital. In order to protect workers, the department started a desynchronisation strategy on March 16th 2020 and ended on May 4th 2020. Moreover, the department implemented a weekly testing regime starting March 23rd 2020. During the desynchronisation period, only the in-hospital group were tested, on Monday and Thursday. For simplicity we assume all workers, in-hospital or doing home office, were tested once a week and the same day. This assumption, is equivalent to assuming the second test was delayed until Monday.

In order to mimic the hospital dynamics, we simulated our system as follows.

  • Set initial conditions to SC = N − 1, IC = 1, EC = HC = DC = RC = 0 and t = −8 and integrate the ODE systems 1–6 until t = 15. No that March 1st 2020 corresponds to t = 0.

  • set initial condition to S1 = S2 = 157 and start stochastic simulation
    1. Select reaction ri and Δt according to the Gillespie algorithm.
    2. Update the variables.
    3. Integrate the ODE system for Δt.
    4. Starting t = 22 we perform tests weekly.
    5. At t = 64 the desynchronisation stops and the two groups are merged together.
    6. If t < tend go to 1. Otherwise end the simulation.

All details of the simulation algorithm have been included in S1 File.

To avoid large step-sizes selected by the Gillespie algorithm, we added an artificial reaction ∅ → ∅ at a rate 100 days−1. This reaction avoids possible problems coupling the deterministic variables of the city with the stochastic variables of the hospital. For example, when α(t) is small and all workers are susceptible or recovered, the Gillespie algorithm would select a large step size. However, α could increase substantially during that long period of time, leading to possible errors.

The fit for the first wave was done by minimizing the equation

G(β,γ)=i=0n((Qi(ti)-O(ti))2, (17)

at times ti = 61 and ti = 91, where Qi(t) is the cumulative Q at time t and O(t) is the cumulative positive tests in the experiment. The two selected time points represent the end of the first wave, selected to account for the total number of infected, and a month after a period in which there were no detected cases.

Analogously, the fit for the second wave was done by minimizing Eq 17 at ti = 191, 291, and 346.

Work productivity. In order to study how protective strategies affect work output we defined a variable, W, accounting for work done by healthy individuals, and given by:

dWdt=S+E+A+R+ϵ5μQ (18)

where ϵ5 indicates the proportion of individuals in quarantine that feel healthy and can work (i.e. asymptomatic) and μ is the productivity of a health worker when in quarantine/working from home compared to that when working at the hospital. In particular, μ accounts for the fact that the tasks that can be carried out from home by most healthcare workers are limited and will thus reduce their overall normal output [14].

In the case of individuals in a desynchronisation strategy, the work done is given by:

dWdt=(S1+E1+A1+R1+ϵ5μQ1)+μ(S2+E2+A2+R2+ϵ5Q2) (19)

In our simulations, the worked is accounted between t = 15 and t = 364.

Parameters of the model. All the parameters of the model are given in Table 2.

Table 2. Parameters of the models.
Parameter Value Description
a varied (see text) fraction of transmission rate outside the hospital
β varied (see text) Transmission rate between coworkers
γ varied (see text) Transmission rate from hospitalised patients
1/s 5.2 days [15] Latency period
1/r 6 days [16] Recovery rate
1/w 10 days [16] Recovery rate for hospitalised patients
1/h 6 days [16] Hospitalisation rate
1/d 10 days Death rate
ϵ 1 2.5% Probability of being hospitalised
ϵ 2 30% (assumption) Probability of being Infectious symptomatic
ϵ 3 95% Probability of a true positive test
ϵ 4 0.37 Probability of death
ϵ 5 0.7 Proportion of healthy individuals in quarantine
f p varied (see text) Fraction of workers tested
π estimated infection rate in the city
κ estimated Relative transmission in the city after NPIs
ν estimated Slope of the sigmoid function
τ varied (see text) Midpoint of transmission reduction
N 1,034,977 [17] Population in Canton Bern
NH 314 Healthcare workforce

Cost analyses

In order to compare the intervention strategies from an economic point of view, we estimated the cost of both testing and desynchronisation. We estimated the cost of each test to be ∼ USD 42 which includes the cost of swabbing material, protective masks, and extraction and qPCR reagents, and the salary of the workers doing the tests. The cost of testing is described by

c=(costpertest)·(Numberoftests)

The cost of home-office during a desynchronisation strategy was considered to be the proportion of the monthly salary that would correspond to the unproductive period. The average monthly wage of a healthcare professional in Switzerland was obtained from the International Labour Organisation for year 2016 (USD 7065.2) [18].

Data availability

The data of the internal testing pipeline is included as S2 File.

Results

Implementation of an internal RT-PCR-based testing protocol on healthcare worker

Starting March 23, 2020, we implemented an RT-PCR-based testing pipeline as a clinical service of the department for Visceral Surgery and Medicine at the Bern University Hospital (Fig 1A). The RT-PCR was developed within our department. Consenting participants were tested in a voluntary basis in one of the two rounds of testing performed weekly, regardless of whether they presented symptoms. Our population consists of 314 persons working in contact with patients and 58 persons who were not working in contact with patients who all attended at least five sessions or were identified positive.

Fig 1. Results of the testing pipeline in asymptomatic healthcare workers.

Fig 1

(A) Number of tests (left y-axis) and number of positive tests (right y-axis) for two different thresholds of the Ct value of the PCR test, 32 and 40, for the healthcare workers in contact with patients. (B) Number of the sum of the last 7 days of official positive cases, sum of the last 7 days of official hospitalized cases, and positive cases for the healthcare workers. (C) Kaplan-Meier curves of infected workers healthcare workers distinguishing healthcare workers and workers without contact with patients. (D) Boxplot showing the Ct value observed in the infected healthcare workers that reported having symptoms and the healthcare workers without symptoms.

Throughout the study period, the number of weekly tests performed among the 314 healthcare workers in contact with patients is shown in Fig 1A, corresponding to a weekly participation of ∼ 65% in the first wave and a participation of ∼ 45% during the second wave and until end of February. Included individuals were aged 18–64 and working in different healthcare roles, including medical doctors, nurses, medico-technical and laboratory staff, in potential direct contact with COVID-19 patients or samples.

At the end of the reported study and considering an RT-PCR Ct cut-off of 32 (see Methods), 15 individuals in potential direct contact with COVID-19 patients or samples tested positive (Fig 1A, red bars), and with a cut-off of 40, positive tests were observed in 30 individuals.

Positive cases were informed, were retested by the official testing protocol, and sent to self-isolation even if asymptomatic.

The peaks of infected healthcare workers occurred with a two week delay to the peaks in the population in both waves of the COVID-19 epidemic in the Canton Bern (Fig 1B). Incidence of infections was higher in healthcare workers with patient contact compared to personnel without patient contact (Fig 1C). Low level positive results (Ct value above 32) matched with the incidence of high level positive results (Ct value below 32). High Ct values were associated with absence of symptoms (Fig 1D).

An epidemiological model that integrates city and hospital transmission dynamics reveals an underestimation of case incidence

We have developed a transmission model that describes the infection dynamics as observed in the Swiss Canton of Bern (City Model, Fig 2A), and integrated the additional infection sources to which a group of healthcare workers might be exposed (Hospital Model, Fig 2A). In the City Model, individuals are exposed to infection at a rate α and become infected after a latent period. A proportion of them are hospitalised, and both hospitalised patients and infected individuals can recover and gain immunity. In the Hospital Model we additionally considered two sources of infection: infected asymptomatic coworkers (given by β) and hospitalised patients (given by γ). After infection, we considered both asymptomatic and symptomatic as infected individuals, we considered deaths only from hospitalised individuals and we did not consider reinfection. Moreover we included a variable Q accounting for individuals who tested positive in the testing pipeline implemented within the department and went into quarantine and represent the fraction of detected cases before presenting symptoms.

Fig 2. Model calibration and integration of test results.

Fig 2

(A) Sketch of the multi-scale epidemiological model accounting for the dynamics in the city and in the hospital. (B) Number of official cases in the canton of Bern compared with the predicted new cases shown by our model. (C) left panel: Error function (see Methods) of the fit for wave 1, right panel: Observed (black curves) and simulated (50 Gillespie simulations, purple curves), and average of 1000 simulations of the 1st wave (blue curves). γ = 14.72, β = 0, a = 1 (D) Error function of the fit for second wave displayed as in (C). γ = 0, β = 0, a = 1. (E) Error function of the fit for second wave for different values of a. (F) Observed and simulated (50 Gillespie simulations), and average of 1000 simulations for the second wave for different values of a. (left) γ = 1.04, β = 0.28, (middle) γ = 0.32, β = 0.24, (right) γ = 0.08, β = 0.12.

The model was fitted to the number of hospitalised patients recorded in the Swiss Canton of Bern [17] (Fig 2B, S1 Fig), which is in line with those reported in other Swiss regions [19], as well as the infection rate in the city, α, which is time-dependent as a results to the implemented policies. We inferred the case incidence in the region (Fig 2B), and showed that the reported data on incidence is an underestimate, likely due to official cases accounting only for test-confirmed cases. Our model predicts a true incidence ∼ 4.0 times higher than confirmed and reported cases during the first wave from March 1st 2020 to May 31st 2020 and up to ∼ 1.75 times higher from June 1st 2020 to March 1st 2021 (Fig 2B).

Household and community transmission alone does not explain case incidence among healthcare workers

The model allowed to independently study the sources of infection that healthcare personnel might be exposed to, namely infection from the community, parameters α and a, from co-workers, β, and from hospitalized patients, γ.

In order to estimate the values of β and γ that can explain the actual cases detected, we fitted the detected cases to Q (Quarantine variable) of our model. Of note, the fraction of detected cases corresponds to the number of pre- and asymptomatic cases detected among the workforce tested through our pipeline –i.e. the E, and A variable in our model– and does not consider individuals who tested positive at other testing centers when already presenting symptoms (i.e. the I variable in the model).

The fit was performed for the two waves of the COVID-19 pandemic separately (Fig 2C and 2D). The results reveal that in the first wave relatively high values of β or γ are necessary to explain our testing data best (Fig 2C left panel). Fig 2C right panel shows the fit using the values of γ and β that result into the best fit obtained from 2C left panel. In the second wave, the low incidence detected in our pipeline could be explained with low values of β and γ (Fig 2D). The best fit is shown in 2D right panel. Transmission by healthcare workers therefore seemed to be lower in the second compared to the first wave.

We tested if the protection from infection in healthcare workers outside the hospital is different compared to the general population and therefore would impact the results. Thus, we decided to study reduced infections from the community by reducing a. In Fig 2E, we observe that for a smaller values of a, an increase in β and γ is necessary to explain the infection rate of healthcare workers and that with decreasing a, the stochastic effects can become more important as we observed for high values of β. The best fits are shown in Fig 2F.

Therefore, modelling based on the results of the continuous testing of healthcare workers allowed to determine the added risks of infection at work for the two waves, and we inferred the transmission rates at the hospital that explain the observed infections.

Regular testing and desynchronisation prevent infection transmission between coworkers

We modelled and studied two intervention measures to reduce infection transmission between coworkers: regularly testing a fraction of individuals, and desynchronisation, where the workers are split in two teams [8].

Fig 3 shows the number of infected workers as a function of a (Fig 3A), β (Fig 3B) and γ (Fig 3C) for different strategies, namely none, testing, desynchronisation and testing+desynchronisation.

Fig 3. Effect of the protective measures.

Fig 3

(A) Number of infected healthcare workers at the end of a simulation for different values of a for the different strategies (none, test, desynchronisation and test+desynchronisation); β = 0.15, γ = 2. (B) Number of infected healthcare workers at the end of a simulation for different values of β for the different strategies; γ = 2, a = 1. (C) Number of infected healthcare workers at the end of a simulation for different values of γ for the different strategies; β = 0.15, a = 1. (D) Fraction of detected cases in as a function of the fraction of workers being tested for different intervals of testing; β = 0.15, γ = 2, a = 1. Parameters β and γ are in units of days−1. test: testing strategy; des: desynchronization strategy, des+test: combining testing and desynchronization strategy.

The results from stochastic simulation on the effect of infection from the city, a, for fixed values of γ and β, are shown in Fig 3A. As expected, the number of total infected workers increase with a. However, we observe no remarkable differences in the behavior of the strategies. Similarly, the number of total infected workers also increases with γ (Fig 3C).

In Fig 3B we studied the effect of infection from co-workers β. In the case of no infection from co-workers (β = 0), testing has no impact, while desynchronisation reduces the number of cases, as a result from decreased infections from hospitalized persons. As β increases, the number of cases and the protective effects of the measures increases. Because stochastic effects become important due to the small number of healthcare workers, the variability increases in parallel. With very large values of β, e.g. 0.6 this increase is reduced because herd immunity may be achieved.

In Fig 3D we show the effect of the frequency of testing and of the fraction of healthcare workers (fraction of testing) that is being tested. Regimes that are included range from testing every 3 days to testing every 14 days. If a specific fraction of persons is not getting tested (e.g. because of logistic reasons) can be compensated by increasing the frequency of testing.

Together, our results showed that the implementation of regular testing of healthcare workers and workforce desynchronisation are effective in preventing worker-worker transmission, and that active adherence to frequent testing is crucial for its efficiency in detecting pre-symptomatic cases.

Regular testing outperforms desynchronisation in work output and cost-effectiveness in Switzerland

Both regular testing and desynchronisation are efficient in reducing transmission between healthcare workers (Fig 3). Nevertheless, both strategies come at a cost: an impact on the overall productivity and the cost of the tests.

Most healthcare workers—notably doctors, nurses, medico-technical and laboratory staff—can carry out limited work at-home. Therefore, a notable decrease in the work output is the consequence of home-office that will be added to that of infected workers.

In order to account for work output of the healthcare cohort, we added a work variable, W, to the model that accounts for the work output of S, E, A, R and Q based on their productivity while working at-home (see Methods).

In the regular testing strategy, total work output is reduced due to workers infected and in quarantine, as well as by the time devoted to the internal testing pipeline, which we estimated as two individuals full work time per day to carry out the testing protocol. In the desynchronisation strategy, work output is reduced due to workers infected and in quarantine, as well as by the decrease in productivity during home-office.

Regular testing has a smaller impact on the overall work than desynchronisation for low home office productivity (Fig 4A). Indicating that testing would be highly efficient and recommended to reduce transmission with a minimal impact of workforce availability at different home-office productivity rates. On the other hand, weekly desynchronisation results in a stronger decrease in productivity, the magnitude of which depends on the proportion of work that is considered to be feasible at home.

Fig 4. Economical impact.

Fig 4

(A) Work output at the end of the simulation as a function of the home office efficiency for the different strategies. (B) Total cost of the measures as a function of the home office efficiency for the different strategies. (C) Total cost of the measures as a function of the cost per test. horizontal lines represent the cost of desynchronization for different levels of home-office productivity. Average of 1000 Gillespie simulations for (A, B, C). test: testing strategy; des: desynchronization strategy; des+test: combining testing and desynchronization strategy.

Next we aim to include the cost of the test in the economic modelling. First we added the cost of the tests in US dollars (USD) and we estimated the cost of the productivity lost during desynchronisation to be proportional to the salary of the worker. For the costs of our in-house test we calculated ∼42 USD per test. With a monthly average wage of 7065.20 USD, the cost of the testing is smaller than the cost of the desynchronisation, unless home office productivity approaches 100% (Fig 4B). However, if a commercially available test has to be applied then the requirements for home office productivity in the desynchronisation strategy would be lower to be cost efficient. In Fig 4C we compared the cost of testing with the cost of desynchronisation as a function of the cost per test.

In summary, our results show that for a pandemic as observed in Bern, Switzerland, a regular internal testing regime would be the optimal strategy to prevent transmission among coworkers while keeping work output high and economic cost low.

Discussion

Protection of healthcare workers during a pandemic requires specific strategies given the elevated risks for healthcare workers from infectious agents due to their role in the treatment of infected patients. We report the results of a testing regime of asymptomatic healthcare workers during the COVID-19 pandemic. Based on the results we have developed a multi-scale epidemiological model that integrates transmission dynamics inside and outside a hospital to describe risks of SARS-CoV-2 infection for healthcare workers.

The results from the testing revealed that the peak incidence from healthcare workers lags 2 weeks behind the peak in the population. Patient contact is associated with increased incidence of infection in healthcare workers. This is supported by other studies showing high viral titers in asymptomatic healthcare workers [20]. We showed that despite the observation that test results with high Ct-values were associated with the absence of symptoms, such results can be used to predict the prevalence of infection in healthcare workers.

Because of underreporting of official cases, especially during the first wave [11], we used hospitalization data to estimate the number of true infections in the city using publicly available data [10] that are in line with estimates in other Swiss studies [11, 19].

The results of the testing were used to build a model to determine sources of infection from inside and outside the hospital. The models show that household infection alone is insufficient to explain the rate of infections in healthcare workers.

We detected that ∼10% of healthcare workers in our cohort had been exposed (positive test with Ct value below 40) until the end of the study. This case incidence among healthcare workers is in line with that reported in other studies [3, 20]. However, estimation of the true case incidence is difficult given the seroprevalence of 1 percent healthcare workers in regions without symptomatic cases [21] up to ∼2.8% [22].

The parameters that are required to explain our observation indicate that for the first wave high infection rates from either co-workers or patients must occur. Conversely for the second wave, the model indicates a lower rate of infection from co-workers or patients. However, it remains to be determined if positive tests with low Ct values in asymptomatic healthcare workers are the consequence of infection from patients or from the community.

Next, we used our model to study how both regular testing and desynchronisation protocols can prevent infection transmission between coworkers. Both strategies are effective in reducing transmission between coworkers, in line with other studies on the benefits of desynchronisation [79]. Our modelling results indicate that a reduced fraction of tested persons can be compensated for by increasing the frequency of testing.

Next, we compared the consequences of the testing and desynchronisation strategies on work productivity and cost-effectiveness. Regular testing results in a minimal impact on workforce availability and work production, whereas a desynchronisation strategy would imply an important decrease on work output unless home-office productivity was virtually the same as in-hospital or in the case in which the cost of the tests is high.

Given the limited tasks that can be carried out at home by health workers—estimated to be less than 50% [14]—and the access to testing resources by medical teams, we concluded that regular testing of healthcare personnel would be the intervention of choice in Switzerland for the current pandemic. However, efforts should be made for future pandemics that prepare for solutions that allow specific tasks to be performed remotely e.g. telepharmacy.

In countries with lower income, desynchronisation would have a lower cost of implementation than testing. However, it would be necessary to asses the impact that halving the available personnel would have on the health system and on the epidemic management as a whole.

A possible limitation is that we assumed an hospitalization rate of 2.5% throughout the epidemic, from which several model parameters are then estimated. Furthermore, we did not consider reinfections among the cohort of healthcare workers over the studied period, but they could be worth including in future models over longer periods where reinfection would be more likely. Although variations in the hospitalization rate and reinfections would lead to different parameters and in turn, case incidence outside and possibly inside the hospital, these do not affect the conclusions of our study regarding the effectiveness of preventive interventions. Further limitations are that the dataset accounts for only one department and cannot be extrapolated to cases where hospitals were saturated.

In summary, our study showed that frequent and widespread testing of pre- and asymptomatic healthcare workers is effective in detecting infections and preventing transmission between coworkers while optimising work output and cost-effectiveness.

Conclusions and outlook

We have generated a unique dataset initiated at the onset of the pandemic that allows the identification of when healthcare workers were infected outside and inside a hospital of interest. The dataset was used to calibrate a mathematical model that allowed the differentiation of the source of infections and to explore different strategies in avoiding future infections.

Future research directions may include the incorporation of other testing strategies and the impact of vaccination.

Taken together, the presented results of continuous testing of healthcare workers, and associated modelling, indicates optimal testing strategies that can be adjusted to the requirements of other institutions.

Supporting information

S1 File. Algorithm.

Pseudocode with the stochastic simulation algorithm.

(ZIP)

S2 File. Data.

Data of the Internal testing pipeline.

(XLSX)

S1 Fig. Optimization fit.

Figure legend: (A) value of α(t) during the simulation period. (b) sum of the last 7 days of HC(t) (red) and sum of the last 7 days of reported hospitalizations (black points).

(PNG)

S2 Fig. Effect of ν constraints.

Figure legend: Effect of the constraints on ν on the fit (a) α(t) (b) Number of hospitalizations during the last 7 days (c) Number of infections during the last 7 days.

(PNG)

Acknowledgments

UVCM-COVID researchers

Andrew Macpherson1,2,3,*, Daniel Candinas1,2,3, Deborah Stroka1,2,3, Monika Wegmüller1, Sandra Wenger1, Lia Bally4, Andreas Melmer4, Mirjam Kneubühl4, Elke Beutler1, Michelle Broger1, Isabel Huber1, Jeannine Kölliker1, Kimberly König1, Joseba Möri1, Chiara Ziegler1, Joana Freitas4, Sophie Lagger4, Elisabeth Leu4, Sandra Tenisch4, Nicole Truffer4, Felix Alexander Baier1,2, Patrick Brönnimann2, Jacopo Gavini1,2, Magdalena Eilenberg1,2, Nicolas Melin1,2, Daniel Rodjakovic1,2, Annina Schmid1,2, Riccardo Tombolini1,2, Katharina Bacher1,2, Marianne Berger Rentsch1,2, Sophie Burkhalter1,2, Marco Felber2, Izzem Gemici3, Dana Leuenberger1,2, Sina Maletti3, Sarah Maring1,2, Jelena Murar1,2, Philip Rubin3, Daniela Sommer-Ezzis1,2, Ziad Al Nabhani1,2, Ian Young1,2

1 Department of Visceral Surgery and Medicine, Bern University Hospital, University of Bern, Switzerland.

2 Department of Biomedical Research, University of Bern, Switzerland.

3 Bern Center for Precision Medicine, Switzerland.

4 of Diabetes, Endocrinology, Nutritional Medicine and Metabolism, Bern University Hospital, University of Bern, Switzerland.

*Lead author: andrew.macpherson@insel.ch

Data Availability

All relevant data and algorithm are within the paper and its Supporting information files.

Funding Statement

The study was supported by the Swiss National Science Foundation with the grants 196059 (G. B., D. S.-T.) and 196641 (S. G.-V.) and by the Bern Center for Precision Medicine (G. B., D. S.-T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1. Gomez-Ochoa Sergio Alejandro, Franco Oscar H., Rojas Lyda Z., Raguindin PeterFrancis, Roa-Diaz Zayne Milena, et al. COVID-19 in Healthcare Workers: A Living Systematic Review and Meta-analysis of Prevalence, Risk Factors, Clinical Characteristics, and Outcomes. Am J Epidemiol. doi: 10.1093/aje/kwaa191 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Schwartz Kevin L., Achonu Camille, Buchan Sarah A., Brown Kevin A., Lee Brenda, Whelan Michael, et al. COVID-19 infections among Healthcare Workers and Transmission within Households. medRxiv, page 2020.06.12.20129619, June 2020. Publisher: Cold Spring Harbor Laboratory Press. [Google Scholar]
  • 3. Folgueira Maria Dolores, Munoz-Ruiperez Carmen, Alonso-Lopez Miguel Angel, Delgado Rafael, and on behalf of the Hospital 12 de Octubre COVID-19 Study Groups. SARS-CoV-2 infection in Health Care Workers in a large public hospital in Madrid, Spain, during March 2020. medRxiv, page 2020.04.07.20055723, April 2020. Publisher: Cold Spring Harbor Laboratory Press. [Google Scholar]
  • 4. Zheng Charlotte, Hafezi-Bakhtiari Nema, Cooper Victoria, Davidson Harriet, Habibi Maximillian, Riley Peter, et al. Characteristics and transmission dynamics of COVID-19 in healthcare workers at a London teaching hospital. medRxiv, page 2020.07.10.20149237, July 2020. Publisher: Cold Spring Harbor Laboratory Press. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Bi Qifang, Lessler Justin, Eckerle Isabella, Lauer Stephen A., Kaiser Laurent, Vuilleumier Nicolas, et al. and for the SEROCoV-POP Study Group. Household Transmission of SARS-CoV-2: Insights from a Population-based Serological Survey. medRxiv, page 2020.11.04.20225573, January 2021. Publisher: Cold Spring Harbor Laboratory Press. [Google Scholar]
  • 6. Byambasuren Oyungerel, Cardona Magnolia, Bell Katy, Clark Justin, McLaws Mary-Louise, and Glasziou Paul. Estimating the extent of asymptomatic COVID-19 and its potential for community transmission: Systematic review and meta-analysis. Official Journal of the Association of Medical Microbiology and Infectious Disease Canada, 5(4):223–234, December 2020. Publisher: University of Toronto Press. doi: 10.3138/jammi-2020-0030 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Karin Omer, Bar-On Yinon M., Milo Tomer, Katzir Itay, Mayo Avi, Korem Yael, et al. Adaptive cyclic exit strategies from lockdown to suppress COVID-19 and allow economic activity. medRxiv, page 2020.04.04.20053579, April 2020. Publisher: Cold Spring Harbor Laboratory Press. [Google Scholar]
  • 8. Sanchez-Taltavull Daniel, Candinas Daniel, Roldan Edgar, and Beldi Guido. Modelling strategies to organize healthcare workforce during pandemics: application to COVID-19. medRxiv, page 2020.03.23.20041863, June 2020. Publisher: Cold Spring Harbor Laboratory Press. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Lim Chun Yee, Bohn Mary Kathryn, Lippi Giuseppe, Ferrari Maurizio, Loh Tze Ping, Yuen Kwok-Yung, et al. Staff rostering, split team arrangement, social distancing (physical distancing) and use of personal protective equipment to minimize risk of workplace transmission during the COVID-19 pandemic: a simulation study. Clinical Biochemistry, September 2020. doi: 10.1016/j.clinbiochem.2020.09.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Federal office of public health foph. https://www.covid19.admin.ch/en/overview. Accessed: 2021-04-09.
  • 11. Althaus Christian L., Probst Daniel, Hauser Anthony, and Riou Julien L. Time is of the essence: containment of the SARS-CoV-2 epidemic in Switzerland from February to May 2020. medRxiv, page 2020.07.21.20158014, July 2020. Publisher: Cold Spring Harbor Laboratory Press. [Google Scholar]
  • 12. Gardiner Crispin. Stochastic methods, volume 4. Springer; Berlin, 2009. [Google Scholar]
  • 13. Gillespie Daniel T. Exact stochastic simulation of coupled chemical reactions. The journal of physical chemistry, 81(25):2340–2361, 1977. doi: 10.1021/j100540a008 [DOI] [Google Scholar]
  • 14. Adams-Prassl Abi, Boneva Teodora, Golin Marta, and Rauh Christopher. Work That Can Be Done from Home: Evidence on Variation within and across Occupations and Industries. page 62, 2020. [Google Scholar]
  • 15. Ganyani Tapiwa, Kremer Cécile, Chen Dongxuan, Torneri Andrea, Faes Christel, Wallinga Jacco, et al. Estimating the generation interval for coronavirus disease (COVID-19) based on symptom onset data, March 2020. Eurosurveillance, 25(17):2000257, April 2020. Publisher: European Centre for Disease Prevention and Control. doi: 10.2807/1560-7917.ES.2020.25.17.2000257 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.K Gaythorpe, N Imai, G Cuomo-Dannenburg, M Baguelin, S Bhatia, A Boonyasiri, et al. Report 8: Symptom progression of COVID-19. Technical report, Imperial College London, March 2020.
  • 17.Daniel Probst. daenuprobst/covid19-cases-switzerland, December 2020. original-date: 2020-03-12T12:09:53Z.
  • 18.Statistics on Wages, https://ilostat.ilo.org/topics/wages/. ILOSTAT, 2021.
  • 19. Lemaitre Joseph C., Perez-Saez Javier, Azman Andrew S., Rinaldo Andrea, and Fellay Jacques. Assessing the impact of non-pharmaceutical interventions on SARS-CoV-2 transmission in Switzerland. Swiss Medical Weekly, 150 (2122), May 2020. Publisher: EMH Media. [DOI] [PubMed] [Google Scholar]
  • 20. McEllistrem M Catherine, Clancy Cornelius J, Buehrle Deanna J, Singh Nina, Lucas Aaron, Sirianni Valerie, et al. Sars-cov-2 is associated with high viral loads in asymptomatic and recently symptomatic healthcare workers. Plos one, 16(3):e0248347, 2021. doi: 10.1371/journal.pone.0248347 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Nopsopon Tanawin, Pongpirul Krit, Chotirosniramit Korn, Jakaew Wutichai, Kaewwijit Chuenkhwan, Kanchana Sawan, et al. Seroprevalence of hospital staff in a province with zero covid-19 cases. PloS one, 16(4):e0238088, 2021. doi: 10.1371/journal.pone.0238088 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Hanrath Aidan T, Van Der Loeff Ina Schim, Lendrem Dennis W, Baker Kenneth F, Price David A, McDowall Peter, et al. Sars-cov-2 testing of 11,884 healthcare workers at an acute nhs hospital trust in england: a retrospective analysis. Frontiers in medicine, 8:239, 2021. doi: 10.3389/fmed.2021.636160 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Etsuro Ito

13 Aug 2021

PONE-D-21-23206

Regular testing of asymptomatic healthcare workers identifies cost-efficient SARS-CoV-2 preventive measures

PLOS ONE

Dear Dr. SANCHEZ-TALTAVULL,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please describe the details of Ct values as one of the reviewers requested.

Please submit your revised manuscript by Sep 23 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Etsuro Ito

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please provide additional details regarding participant consent. In the Methods section, please ensure that you have specified (1) whether consent was informed and (2) what type you obtained (for instance, written or verbal). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information.

3. Please note that PLOS ONE has specific guidelines on code sharing for submissions in which author-generated code underpins the findings in the manuscript. In these cases, all author-generated code must be made available without restrictions upon publication of the work. Please review our guidelines at https://journals.plos.org/plosone/s/materials-and-software-sharing#loc-sharing-code and ensure that your code is shared in a way that follows best practice and facilitates reproducibility and reuse.

4. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. 

When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

5. Thank you for stating the following in the Acknowledgments Section of your manuscript: 

"The study was supported by the Swiss National Science Foundation with the grants

196059 (G. B., D. S.-T.) and 196641 (S. G.-V.) and by the Bern Center for Precision Medicine (G. B., D. S.-T.). "

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. 

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: 

"The study was supported by the Swiss National Science Foundation with the grants 196059 (G. B., D. S.-T.) and 196641 (S. G.-V.) and by the Bern Center for Precision Medicine (G. B., D. S.-T.).

The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

6.One of the noted authors is a group or consortium UVCM-COVID researchers. In addition to naming the author group, please list the individual authors and affiliations within this group in the acknowledgments section of your manuscript. Please also indicate clearly a lead author for this group along with a contact email address.

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: N/A

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Review Comments

1. In the abstract section, please add appropriate key words like testing, SARS COV 2and asymptomatic

2. Add the study design you have used in the abstract section

3. Well-articulated writing style in introduction part but didn’t show the gap why the importance of conducting this study for health workers and patients apart from entire world. Please try to state the importance of conducting this research in the revised manuscript

4. In the method part, better to include sampling procedures

5. Have you checked the confounding factors during testing? Please stated it in the revised manuscript whether you consider confounding variable or not

6. Write strengths and limitation of the study in the revised manuscript

7. Include Conclusion section following discussion part and place recommendation for future investigators

General comments

-The research is novel and will be an input for scientific community after publication

- The authors followed all scientific procedures to conduct the study except some minor comments raised in the above comments

Reviewer #2: Summary:

The authors aim to investigate a set of coupled models to explain the spread of SARS-CoV-2 not only in the Swiss Canton of Bern but also within the local hospital environment.

To do so they present two coupled models. The first is a mean-field compartmental infectious disease model to describe the dynamics of the virus within the surrounding community. The second is a stochastic model (via Gillespie simulations of related ODEs) of the viral dynamics within the healthcare workers.

To parameterize these models, the cumulative infections within Bern were used. Additionally PCR data from voluntary swabs of healthcare workers were used to parameterize the Gillespie model.

Remarks:

1. Numerous times the authors refer to the cycle threshold (Ct), though this quantity is never defined nor explained anywhere in the manuscript (in fact, I do not believe the words "Cycle Threshold" appear anywhere within the manuscript). This quantity should be defined/explained and its importance emphasized within the manuscript. (Perhaps in the RNA and RT-qPCR section). Notably some intuition should be given for the importance of the size / relative ordering of these values. What does a mean Ct of 20 intuitively mean, for the symptomatic group, compared to a Ct of 35 (Fig 1D), for example.

2. The presentation of the pseudo-code on pages 7-9 should be re-considered. In particular, the pseudocode switches between being quite high-level (Select reactions according to Gillespie's algorithm; update the states accordingly) and being quite low-level (explicit for loops in C-like syntax, etc.) In particular, the authors employ a flag variable 'Bol' with a very un-informative name. The flag, presumably, is included so as to ensure that there isn't simulated "double testing" if the Delta t chosen by Gillespie's algorithm is smaller than one day. For some reason, this flag seems to be improperly employed in the t>64 case of the algorithm. (Bol is never reset to 0 suggesting a possibility of this spurious "double testing"). The authors should ensure that this error is only present in the presentation of the algorithm and not in the actual simulations.

The authors should decide if they want to provide a high-level overview here, or a low-level implementation. If the former, then point 2d) and 2e)could be re-written to be more human-readable. If the latter, then there certainly shouldn't be any implementation glitches present within the summary of the algorithm.

Finally, a minor critique, the ending condition for the algorithm is never specified. Presumably after some time point was reached? Should step 3 read: "Go to 2(a) or END if t=365"?

3. The quantity f_p is introduced (line 171 on page 6) and then never used again or explained. (In the implementation of the algorithm, the phrase "Fraction of workers tested" is employed instead, presumably this refers to f_p). It is also unclear to me *what* f_p is. Is f_p a time dependent parameter? f_p is not present in the parameter value table, perhaps f_p is calculated on a per-day basis from the PCR data, in any case this should be made clear.

4. A few typographical issues:

- In the text on lines 180-181, the authors indicate that tau, pi, nu, and kappa are fit via minimizing this cost function. However the cost function as written is only a function of kappa, nu, and pi (notably: not a function of tau, is there a reason for this? Or is there just a typo in line 180 or in the definition of G).

- the integral between lines 181 and 182 is missing the variable of integration (presumably time).

- Lines 51-52 include the sentence "We fitted the model to the recorded number of hospitalized individuals outside the hospital". Presumably the authors mean "infected individuals outside the hospital".

- On line 164 the authors say beta_1(t) = 1.5\\beta, \\gamma_1(t)=\\gamma. and then one line 165, when the desynchronized cohorts switch, they say beta_2(t)=1.5\\beta, \\gamma_2(t)=1.5\\gamma. I assume there is a typo in the definition of \\gamma_1(t) on this interval (probably meant \\gamma_1(t)=1.5\\gamma). If this isn't a typo, this discrepancy should be explained. Also, on lines 216 and 217 they define \\gamma_1=\\gamma and \\gamma_2=\\gamma and not 1.5\\gamma, in contradiction with definitions of \\gamma_i(t) earlier and in contradiction with line 166 that states "We assume an increase of 50% in beta and gamma..."

- Perhaps a nitpicky critique, but it would be good around lines 155-167 to discuss WHEN the bare values of \\gamma and \\beta are actually used. The definition of \\beta_i switching between 1.5\\beta and 0 in lines 155-167 naturally raises the question: why not just redefine \\beta as this 50% increase of the nominal value? This isn't answered until a full two-pages later in line 248 where it becomes clear that the bare value of \\beta is used within the simulations when desynchronization is not considered.

- There are overbars on some quantities in equations (9) and (10). Are these just typographical errors or is this meant to indicate something else? Notably these bars are absent in the corresponding terms in Table 1.

5. Perhaps I am missing something, but I fundamentally do not understand the point being made in lines 283-285. While I understand that without this artificial reaction there may be situations where large values of delta t are chosen by Gillespie's algorithm, I fail to understand how this relates to errors in the solution of the ODE system. My understanding of the algorithm is as follows:

- The city ODE model is integrated for 8 days. During this time the Gillespie model is not being used.

- Then the Gillespie model is initialized and chooses a reaction and a delta t. The Gillespie state vectors are updated accordingly.

- Then the city ODE model is integrated for delta t days.

- (Then testing updates, desynch turning on and off, etc.)

I assume that the large delta t values that "lead to errors in the solution of the ODE system" that the authors refer to would be introduced at this third step of my summary. I just fail to see why that is necessarily the case. delta t, the step size for the Gillespie simulation, is not necessarily the step size for the ODE solver. It is just the final time of the time-mesh used by the ODE solver. Why not define a maximum step size, h_t say, that is sufficiently small (i.e. h_t=0.01 or smaller) and integrate the city ODE over the time mesh [t_i, t_i + h_t, t_i + 2 h_t, ..., t_i + delta t]. You then will not be sacrificing accuracy in the integration of the ODE system while not introducing an artificial reaction in the Gillespie simulation.

Partially the reason this concerns me is that with the artificial reaction I am not convinced that a Gillespie simulation is actually being employed. i.e. It almost reads as just a Monte-Carlo step with a completely spurious temporal update.

6. It is not clear to me why alpha(t) switches form throughout the simulation. It is this Holling Type-2 function during waves 1 and 2 and during the winter after wave 2, but a constant function between waves 1 and 2. Is there any explanation as to why this choice was made? What happens if between waves it is treated as having the same functional form? Additionally, it would be good to see a plot of alpha(t) for all time being considered (perhaps in the SI, at the authors' discretion).

7. The fitting/optimization process is not discussed in nearly enough detail. Is it just a brute force method over the lattice of values presented in the "Model Fitting - City" section? Is some other optimization algorithm being employed instead?

8. The authors (line 202-205) discuss how in actuality testing was performed on the in-hospital cohort only (on a voluntary basis) and not on the home-office cohort. They then simulate testing on both cohorts "for simplicity". I do not find this to be an acceptable assumption (though the authors may disagree with evidence to the contrary!). Simulating testing only once a week instead of twice a week is, admittedly, unlikely to change terribly much dynamically (and hence seems to be a reasonable assumption, though I still think it would be incredibly simple to simulate this testing twice a week instead, but that is of little consequence), however it is the other assumption here that concerns me the most: why not simulate tests on only one of the cohorts? This seems like an incredibly simple addition to add to the code, as presented, (something like 'if beta_2==0, then do the tests on E1 and A1, else do the tests on E2 and A2').

Also: why simulate these tests on *everyone*? Presumably the authors know how many people were tested within a given week and could include that relatively simply here?

9. The Epi Data on lines 62-65 should be clarified. Are these daily time series or weekly time series? Are these cumulative hospitalizations, deaths, and cases or are they only new hospitalizations, deaths, and cases?

10. Paragraph on lines 286-289 should be rewritten for clarity. This is a particularly important part of the process and comprehension is harmed by the brevity. It is not clear to me what is happening in this paragraph; additional equations here would be an asset! You're redefining the cost function from Eqn. 15, so why not just present the actual functional form of the second cost function here and reduce ambiguity. What do you mean by "minimizing the function at times t=61 and 91"? Minimizing at time t=61 will give you one answer and at t=91 will give you a second, are you equally weighting these two options? Why not minimize the function over the whole time period, as is more commonly done? Or doing some kind of sum-of-squares of weekly minimization, as you did with the original cost function in lines 180-182?

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Mohammedjud Hassen Ahmed

Reviewer #2: Yes: Brydon Eastman

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: PLOS review.docx

PLoS One. 2021 Nov 5;16(11):e0258700. doi: 10.1371/journal.pone.0258700.r002

Author response to Decision Letter 0


21 Sep 2021

We thank the reviewers for their comments and suggestions that we believes have substantially improved the quality of our manuscript. We have addressed all the issues raised during the review process. A detailed explanation can be find in the ResponseToReviewers.pdf file.

Attachment

Submitted filename: responsetoreviewers.pdf

Decision Letter 1

Etsuro Ito

4 Oct 2021

Regular testing of asymptomatic healthcare workers identifies cost-efficient SARS-CoV-2 preventive measures

PONE-D-21-23206R1

Dear Dr. SANCHEZ-TALTAVULL,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Etsuro Ito

Academic Editor

PLOS ONE

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: (No Response)

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: (No Response)

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: (No Response)

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: (No Response)

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: (No Response)

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

Reviewer #2: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Mohammedjud Hassen Ahmed

Reviewer #2: Yes: Brydon Eastman

Acceptance letter

Etsuro Ito

28 Oct 2021

PONE-D-21-23206R1

Regular testing of asymptomatic healthcare workers identifies cost-efficient SARS-CoV-2 preventive measures

Dear Dr. SANCHEZ-TALTAVULL:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Prof. Etsuro Ito

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File. Algorithm.

    Pseudocode with the stochastic simulation algorithm.

    (ZIP)

    S2 File. Data.

    Data of the Internal testing pipeline.

    (XLSX)

    S1 Fig. Optimization fit.

    Figure legend: (A) value of α(t) during the simulation period. (b) sum of the last 7 days of HC(t) (red) and sum of the last 7 days of reported hospitalizations (black points).

    (PNG)

    S2 Fig. Effect of ν constraints.

    Figure legend: Effect of the constraints on ν on the fit (a) α(t) (b) Number of hospitalizations during the last 7 days (c) Number of infections during the last 7 days.

    (PNG)

    Attachment

    Submitted filename: PLOS review.docx

    Attachment

    Submitted filename: responsetoreviewers.pdf

    Data Availability Statement

    All relevant data and algorithm are within the paper and its Supporting information files.

    The data of the internal testing pipeline is included as S2 File.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES